BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36973198)

  • 1. [Mutation characteristics of osteosarcoma: a single center study of 64 cases using next-generation sequencing].
    Gao DL; Dong RF; Liu WF; Gong LH; Xu HR; Niu XH; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):370-375. PubMed ID: 36973198
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular profiling of osteosarcoma in children and adolescents from different age groups using a next-generation sequencing panel.
    Guimarães GM; Tesser-Gamba F; Petrilli AS; Donato-Macedo CRP; Alves MTS; de Lima FT; Garcia-Filho RJ; Oliveira R; Toledo SRC
    Cancer Genet; 2021 Nov; 258-259():85-92. PubMed ID: 34666222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.
    Chen X; Bahrami A; Pappo A; Easton J; Dalton J; Hedlund E; Ellison D; Shurtleff S; Wu G; Wei L; Parker M; Rusch M; Nagahawatte P; Wu J; Mao S; Boggs K; Mulder H; Yergeau D; Lu C; Ding L; Edmonson M; Qu C; Wang J; Li Y; Navid F; Daw NC; Mardis ER; Wilson RK; Downing JR; Zhang J; Dyer MA;
    Cell Rep; 2014 Apr; 7(1):104-12. PubMed ID: 24703847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations.
    Bousquet M; Noirot C; Accadbled F; Sales de Gauzy J; Castex MP; Brousset P; Gomez-Brouchet A
    Ann Oncol; 2016 Apr; 27(4):738-44. PubMed ID: 26787232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Targeted Next-Generation Panel Sequencing Reveals
    Marinoff AE; Spurr LF; Fong C; Li YY; Forrest SJ; Ward A; Doan D; Corson L; Mauguen A; Pinto N; Maese L; Colace S; Macy ME; Kim A; Sabnis AJ; Applebaum MA; Laetsch TW; Glade-Bender J; Weiser DA; Anderson M; Crompton BD; Meyers P; Zehir A; MacConaill L; Lindeman N; Nowak JA; Ladanyi M; Church AJ; Cherniack AD; Shukla N; Janeway KA
    JCO Precis Oncol; 2023 Mar; 7():e2200334. PubMed ID: 36996377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine.
    Subbiah V; Wagner MJ; McGuire MF; Sarwari NM; Devarajan E; Lewis VO; Westin S; Kato S; Brown RE; Anderson P
    Oncotarget; 2015 Dec; 6(38):40642-54. PubMed ID: 26510912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of mutations in leiomyosarcomas identified by clinical targeted next-generation sequencing.
    Lee PJ; Yoo NS; Hagemann IS; Pfeifer JD; Cottrell CE; Abel HJ; Duncavage EJ
    Exp Mol Pathol; 2017 Feb; 102(1):156-161. PubMed ID: 28093192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
    Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA
    JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary Application of Precision Genomic Medicine Detecting Gene Variation in Patients with Multifocal Osteosarcoma.
    Zhang HQ; Li MH; Gao P; Lan PH; Fan B; Xiao X; Lu YJ; Chen GJ; Wang Z
    Orthop Surg; 2016 May; 8(2):129-38. PubMed ID: 27384721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma.
    Negri GL; Grande BM; Delaidelli A; El-Naggar A; Cochrane D; Lau CC; Triche TJ; Moore RA; Jones SJ; Montpetit A; Marra MA; Malkin D; Morin RD; Sorensen PH
    J Pathol; 2019 Nov; 249(3):319-331. PubMed ID: 31236944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RUNX2 (6p21.1) amplification in osteosarcoma.
    Gupta S; Ito T; Alex D; Vanderbilt CM; Chang JC; Islamdoust N; Zhang Y; Nafa K; Healey J; Ladanyi M; Hameed MR
    Hum Pathol; 2019 Dec; 94():23-28. PubMed ID: 31669178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does ATRX germline variation predispose to osteosarcoma? Three additional cases of osteosarcoma in two ATR-X syndrome patients.
    Masliah-Planchon J; Lévy D; Héron D; Giuliano F; Badens C; Fréneaux P; Galmiche L; Guinebretierre JM; Cellier C; Waterfall JJ; Aït-Raïs K; Pierron G; Glorion C; Desguerre I; Soler C; Deville A; Delattre O; Michon J; Bourdeaut F
    Eur J Hum Genet; 2018 Aug; 26(8):1217-1221. PubMed ID: 29706636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing.
    Zou Y; Li J; Hua P; Liang T; Ji X; Zhao P
    Mol Vis; 2021; 27():1-16. PubMed ID: 33456302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations.
    Suehara Y; Alex D; Bowman A; Middha S; Zehir A; Chakravarty D; Wang L; Jour G; Nafa K; Hayashi T; Jungbluth AA; Frosina D; Slotkin E; Shukla N; Meyers P; Healey JH; Hameed M; Ladanyi M
    Clin Cancer Res; 2019 Nov; 25(21):6346-6356. PubMed ID: 31175097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors.
    Freeman SS; Allen SW; Ganti R; Wu J; Ma J; Su X; Neale G; Dome JS; Daw NC; Khoury JD
    Cancer; 2008 Sep; 113(6):1453-61. PubMed ID: 18704985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomics and the Immune Landscape of Osteosarcoma.
    Wu CC; Livingston JA
    Adv Exp Med Biol; 2020; 1258():21-36. PubMed ID: 32767232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
    Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
    Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized chemotherapy for osteosarcoma and identification of gene mutations in osteosarcoma.
    Xiao X; Wang W; Zhang H; Gao P; Fan B; Huang C; Fu J; Chen G; Shi L; Zhu H; Li X; Li J; Fan H; Wu Z; Guo Z; Hu Y; Wu S; Yu X; Xu C; Wang Z
    Tumour Biol; 2015 Apr; 36(4):2427-35. PubMed ID: 25431261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced mitochondrial DNA copy number in Chinese patients with osteosarcoma.
    Yu M; Wan Y; Zou Q
    Transl Res; 2013 Mar; 161(3):165-71. PubMed ID: 23177796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Array comparative genomic hybridization reveals frequent alterations of G1/S checkpoint genes in undifferentiated pleomorphic sarcoma of bone.
    Niini T; Lahti L; Michelacci F; Ninomiya S; Hattinger CM; Guled M; Böhling T; Picci P; Serra M; Knuutila S
    Genes Chromosomes Cancer; 2011 May; 50(5):291-306. PubMed ID: 21254299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.